@CNN: Irish drugmaker Amarin announced to investors that Vascepa, a purified fish oil derivative, was linked to a 25% reduced risk of major cardiovascular events. With few other details and no published data, some doctors held their applause. https://t.co/mRzIAJarEk https://t.co/gSRcv82bKg
Irish drugmaker Amarin announced to investors that Vascepa, a purified fish oil derivative, was linked to a 25% reduced risk of major cardiovascular events. With few other details and no published data, some doctors held their applause. https://t.co/mRzIAJarEk pic.twitter.com/gSRcv82bKg
— CNN (@CNN) September 25, 2018